🇺🇸 FDA

Company profile · Sponsor

NORTHWEST

NORTHWEST BIOTHERAPEUTICS INC

NWBO · NYSE pharma BETHESDA, MD, USA
Pipeline
24
Drugs
0
Patents
8

Quick answer

NORTHWEST (NWBO) is a pharma company. headquartered in BETHESDA, MD, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker NWBO
Exchange NYSE
Company type pharma
Headquarters BETHESDA, MD, USA
SEC CIK 0001072379

Pipeline (24)

Search pipeline →

  1. Dendritic cell immunotherapy

    NORTHWEST

    Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  2. Dendritic cell immunotherapy

    NORTHWEST

    Glioblastoma Multiforme

    phase 3 small molecule active

    1 trial

  3. gemcitabine

    NORTHWEST

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  4. Administration of experimental treatment association (sotorasib, panitumumab 5FU)

    NORTHWEST

    Colorectal Carcinoma

    phase 2 small molecule active

    1 trial

  5. Carvedilol

    NORTHWEST

    Post-Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  6. DCVax-Direct

    NORTHWEST

    Locally Advanced Tumor

    phase 2 mab active

    1 trial

  7. DCVax-L and T Cells

    NORTHWEST

    Ovarian Cancer

    phase 2 mab terminated

    1 trial

  8. Leuprolide or goserelin

    NORTHWEST

    Cancer

    phase 2 small molecule completed

    1 trial

  9. Lithium Carbonate

    NORTHWEST

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial

  10. Pear

    NORTHWEST

    Metabolic Syndrome

    phase 2 other completed

    1 trial

  11. Premier Lifestyle Intervention with DASH Diet

    NORTHWEST

    Weight Loss

    phase 2 other completed

    1 trial

  12. Vitamin E

    NORTHWEST

    Nonalcoholic Fatty Liver Disease

    phase 2 small molecule completed

    1 trial

  13. Xanthohumol

    NORTHWEST

    Crohn Disease

    phase 2 small molecule active

    1 trial

  14. autologous dendritic cells pulsed with tumor lysate antigen Vaccine

    NORTHWEST

    Giant Cell Glioblastoma

    phase 2 mab terminated

    1 trial

  15. DCVac-L

    NORTHWEST

    Ovarian Cancer

    phase 1 mab completed

    1 trial

  16. DCVax-Direct

    NORTHWEST

    Brain Metastases

    phase 1 mab active

    1 trial

  17. Gonadotrophin releasing hormone agonist(GnRHa)

    NORTHWEST

    GnRHa;LPS

    phase 1 small molecule active

    1 trial

  18. Menopur 150 international units

    NORTHWEST

    Pregnancy

    phase 1 small molecule terminated

    1 trial

  19. Omega-3 fatty acids

    NORTHWEST

    Metabolic Syndrome X

    phase 1 other active

    1 trial

  20. Xanthohumol

    NORTHWEST

    Healthy

    phase 1 small molecule active

    1 trial

  21. [14C]-benzo[a]pyrene

    NORTHWEST

    Environmental Exposure

    phase 1 small molecule completed

    3 trials

  22. interceptive orthodontic treatments

    NORTHWEST

    Malocclusion

    phase 1 other active

    1 trial

  23. Ketamine Hydrochloride

    NORTHWEST

    Revision Spine Surgery

    approved small molecule active

    1 trial

  24. Mifepristone

    NORTHWEST

    Pregnancy Related

    approved small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12421280

    Insulin like growth factor binding protein bioactive peptide fragments

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12415995

    Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12414981

    JNK inhibitors for use in treating and preventing neurodegenerative disorders

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12414963

    Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12414995

    Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12409205

    Nanomolecules for the treatment of inflammatory bowel diseases

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12410474

    Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patient

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12404533

    Bioconjugate vaccines' synthesis in prokaryotic cell lysates

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is NORTHWEST?

NORTHWEST (NWBO) is a pharma company. headquartered in BETHESDA, MD, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does NORTHWEST sponsor?

We track 24 ClinicalTrials.gov-linked programs for NORTHWEST, including Dendritic cell immunotherapy and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does NORTHWEST company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.